HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Colin L Masters Selected Research

florbenazine F 18

1/2012Differential diagnosis in Alzheimer's disease and dementia with Lewy bodies via VMAT2 and amyloid imaging.
7/2011In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Colin L Masters Research Topics

Disease

341Alzheimer Disease (Alzheimer's Disease)
11/2022 - 01/2002
118Cognitive Dysfunction
05/2022 - 10/2004
64Dementia (Dementias)
11/2022 - 07/2002
34Neurodegenerative Diseases (Neurodegenerative Disease)
11/2020 - 04/2002
30Parkinson Disease (Parkinson's Disease)
10/2021 - 07/2002
29Amyloid Plaque
07/2022 - 05/2002
29Prion Diseases (Transmissible Spongiform Encephalopathies)
07/2021 - 06/2002
28Atrophy
05/2022 - 03/2010
25Disease Progression
04/2022 - 12/2004
11Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
11/2022 - 10/2002
8Infections
03/2014 - 11/2005
6Amyloidosis
01/2022 - 03/2005
5Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
01/2022 - 06/2002
5Gliosis
01/2021 - 01/2006
5Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2020 - 06/2002
5Frontotemporal Dementia (Semantic Dementia)
01/2016 - 04/2002
5Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
06/2014 - 12/2004
5Neuroblastoma
01/2008 - 03/2005
4Proteostasis Deficiencies
07/2022 - 11/2009
4Inflammation (Inflammations)
04/2022 - 01/2016
4Cerebral Cortical Thinning
01/2020 - 11/2013
4Sporadic Creutzfeldt-Jakob Disease
04/2018 - 10/2007
4Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
10/2012 - 05/2010
4Traumatic Brain Injuries (Traumatic Brain Injury)
07/2012 - 03/2011
3Hypertension (High Blood Pressure)
01/2022 - 04/2011
3Tauopathies
01/2021 - 12/2013
3Cardiovascular Diseases (Cardiovascular Disease)
11/2018 - 06/2002
2Hemorrhage
01/2022 - 01/2014
2Cerebral Hemorrhage
01/2022 - 01/2014
2Down Syndrome (Down's Syndrome)
01/2021 - 11/2014
2Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
01/2019 - 08/2011
2Neoplasms (Cancer)
10/2018 - 01/2008
2Memory Disorders (Memory Loss)
11/2017 - 03/2011
2Mitochondrial Diseases (Mitochondrial Disease)
11/2016 - 06/2007
2Cataract (Cataracts)
01/2016 - 04/2003
2Acquired CJD
12/2013 - 10/2012

Drug/Important Bio-Agent (IBA)

208Amyloid (Amyloid Fibrils)IBA
10/2022 - 01/2002
139Biomarkers (Surrogate Marker)IBA
11/2022 - 02/2006
92Amyloid beta-PeptidesIBA
07/2022 - 06/2002
66Proteins (Proteins, Gene)FDA Link
07/2022 - 01/2002
50Peptides (Polypeptides)IBA
07/2022 - 06/2002
32Apolipoproteins E (ApoE)IBA
11/2022 - 01/2011
22CopperIBA
01/2013 - 01/2002
21MetalsIBA
11/2016 - 11/2002
20Prion ProteinsIBA
07/2015 - 06/2002
18alpha-SynucleinIBA
09/2021 - 07/2002
172- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA
10/2021 - 04/2007
16ApolipoproteinsIBA
11/2022 - 07/2013
14PrionsIBA
11/2020 - 11/2005
11IronIBA
09/2021 - 11/2002
11Amyloid Precursor Protein Secretases (beta-Secretase)IBA
01/2019 - 06/2002
9LipidsIBA
11/2022 - 01/2003
9Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2022 - 11/2013
9tau Proteins (tau Protein)IBA
01/2021 - 11/2010
8Protein Isoforms (Isoforms)IBA
01/2021 - 05/2002
8IonsIBA
11/2016 - 01/2003
8Reactive Oxygen Species (Oxygen Radicals)IBA
08/2011 - 06/2005
7Biological ProductsIBA
01/2022 - 02/2012
7ZincIBA
07/2014 - 04/2005
6Pharmaceutical PreparationsIBA
10/2021 - 12/2004
6SynucleinsIBA
01/2021 - 08/2002
5Blood Proteins (Serum Proteins)IBA
01/2022 - 01/2017
54- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA
01/2017 - 02/2008
5Peptide Hydrolases (Proteases)FDA Link
03/2014 - 10/2009
5Trace Elements (Biometals)IBA
01/2012 - 04/2004
4Pyrrolidonecarboxylic Acid (Pyroglutamic Acid)IBA
10/2021 - 12/2010
4dityrosineIBA
10/2021 - 03/2007
414-3-3 Proteins (14-3-3 Protein)IBA
07/2021 - 12/2013
4PresenilinsIBA
01/2021 - 01/2004
4Hormones (Hormone)IBA
11/2020 - 01/2004
4CholesterolIBA
01/2020 - 01/2003
4AntioxidantsIBA
01/2017 - 08/2006
4LigandsIBA
04/2011 - 11/2007
4Clioquinol (Vioform)FDA Link
07/2008 - 12/2003
4Amino AcidsFDA Link
06/2008 - 12/2005
4Amyloid beta-Protein Precursor (Amyloid Protein Precursor)IBA
03/2005 - 06/2002
4Presenilin-1IBA
01/2004 - 04/2002
3MicroRNAs (MicroRNA)IBA
01/2022 - 01/2020
3RNA (Ribonucleic Acid)IBA
06/2020 - 08/2010
3Glucose (Dextrose)FDA LinkGeneric
01/2019 - 11/2013
3Indicators and Reagents (Reagents)IBA
09/2015 - 11/2012
32- (4- aminophenyl)- 6- (2- fluoroethoxy)quinolineIBA
05/2014 - 04/2011
3PrPSc ProteinsIBA
08/2011 - 01/2006
3EnzymesIBA
12/2010 - 06/2002
3Superoxide DismutaseIBA
07/2008 - 10/2002
2Threonine (L-Threonine)FDA Link
01/2022 - 01/2021
28-hydroxyquinazolin-4(3H)-oneIBA
09/2021 - 01/2017
2Presenilin-2IBA
01/2021 - 08/2004
2Transferrin (beta 2 Transferrin)IBA
01/2020 - 03/2015
2Retinaldehyde (Retinal)IBA
01/2019 - 09/2009
2SeleniumIBA
01/2017 - 01/2017
2DNA (Deoxyribonucleic Acid)IBA
01/2016 - 06/2002
2Superoxide Dismutase-1IBA
06/2014 - 04/2006
2Folic Acid (Vitamin M)FDA LinkGeneric
01/2014 - 01/2011
2Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
01/2014 - 01/2011
2PlatinumIBA
03/2013 - 05/2008

Therapy/Procedure

24Therapeutics
01/2022 - 10/2002
3Immunotherapy
12/2021 - 09/2011
3Secondary Prevention
01/2020 - 11/2016
3Lasers (Laser)
01/2016 - 12/2002